Atossa Therapeutics, Inc
Price
FilingsNewest: 8-K, Other eventsSep 29 →InsidersNo open-market buys or sales.→HoldersVanguard 3.6%Ameriprise Financial 2.6%BlackRock 1.6%→Financing →PeersClosest companies: COGT, CRIS, GRI→
From the filings
Figures
- Net income
- −$37.7Mlast 12 months
- Operating cash flow
- −$33.4Mlast 12 months
- Cash and equivalents
- $26.1Mat the last balance sheet
- Shares outstanding
- 10.0M shareson issue